-
Pyjamas and bets: Brazil YouTube channel reshapes World Cup viewing
-
Bloodied but unbowed: Sinner avoids shock exit at start of Wimbledon title defence
-
Queueing, strawberries and all white: it must be Wimbledon
-
Top US court upholds $5mn Trump sex assault judgment
-
Stokes backs Brook '100 percent' to succeed him as England Test captain
-
Sinner survives scare to reach Wimbledon second round
-
Ebola outbreak in DR Congo spreads to fourth province
-
Six killed in German 'family tragedy' shooting: police
-
Czech Republic coach Koubek quits after World Cup flop
-
Osaka makes spectacular Wimbledon arrival in kimono-inspired dress
-
French parliament adopts bill to regulate fast fashion
-
Bolivia removes 15-year dollar peg in bid to revive economy
-
Supreme Court boosts Trump's power to fire officials, but protects Fed
-
Russia jails veteran who threatened Putin with mutiny
-
Three things we learned from the Austrian F1 Grand Prix
-
Five shot dead at German youth welfare site, two suspects arrested
-
Burnham pledges radical devolution of UK govt if PM
-
New Zealand thrash England to deny Stokes a fairytale finish
-
Polish businesses press Warsaw, Kyiv to end political rift
-
Tour de France 'ready to adapt' amid extreme heatwave
-
Hovland beats Scheffler in playoff for PGA Travelers title
-
Stocks rise, oil climbs after US-Iran clashes
-
New Zealand thrash England for series win as Stokes bows out
-
Man City hire Maresca to start new era after Guardiola
-
Trump says Iran meeting to take place in Qatar
-
Pegula slams Vondrousova's 'harsh' doping ban
-
Spain raises 2026 growth forecast despite Mideast war turmoil
-
Chavez-era housing complex in ruins after Venezuela quakes
-
Kenya-US rare earths deal challenged in court over secrecy
-
Sinner, Djokovic set to start Wimbledon title charge
-
Santner strikes as New Zealand eye England series win
-
Pakistan launches deadliest attack on Afghanistan in months
-
Broos may change decision to quit as South Africa coach
-
Strauss 'dumbfounded' by timing of Stokes's England exit
-
French swim star Marchand suffers injury scare before Europeans
-
Monza turn to Juric for return to Serie A
-
France skipper Dupont to miss Nations Championship
-
Stocks mixed, oil edges up after US-Iran clashes
-
Springbok milestones loom for Willemse and Kolbe against England
-
Catholic traditionalists risk schism in Church
-
Tennis players end Wimbledon prize-money protest
-
Europe's deadly heatwave scorches eastern flank, takes aim at Ukraine
-
Pogacar rides with Del Toro and Yates in quest for fifth Tour de France
-
PSG in talks with Leipzig to buy Ivory Coast star Diomande
-
Australia to host Brazil double-header after World Cup
-
Venezuela search teams scramble as hope fades of finding quake survivors
-
Stocks rise and oil edges up as US, Iran call end to latest attacks
-
Bondi Beach attack survivor tells of 'trauma' of online AI images
-
South Korea to invest nearly $1.2 tn in chips, AI data centres
-
Pakistan strikes on eastern Afghanistan kill dozens
AVTRMed Selected as Member of NVIDIA Inception Program, Advancing its Enterprise AI Platform for Healthcare Delivery
Selection validates AVTRMed's technical architecture and accelerates its go-to-market strategy for scaling its intelligent automation platform
DAKOTA DUNES, SOUTH DAKOTA / ACCESS Newswire / February 9, 2026 / AVTRMed, Inc., a healthcare AI company building autonomous clinical workflow solutions, today announced its acceptance into the NVIDIA Inception program, a global initiative supporting startups developing transformative technologies in artificial intelligence and accelerated computing.
The NVIDIA Inception program provides AVTRMed with access to NVIDIA's advanced AI frameworks, infrastructure, technical expertise and capabilities to scale its eye care platform and later expand to additional healthcare verticals. Selection into the program validates AVTRMed's technical architecture and solidifies its position in the rapidly growing AI-enabled healthcare sector.
"Joining NVIDIA Inception is a strategic milestone that validates our mission and strengthens our foundation for sustained growth," says Dr. Steven Ferguson, CEO of AVTRMed. "This collaboration empowers AVTRMed to deliver high-impact clinical and operational AI solutions at scale, alongside leading innovators in healthcare AI."
AVTRMed is developing a next-generation platform designed to address structural inefficiencies in healthcare delivery through intelligent, autonomous digital workflows. The company's AI Clinic Assistant is currently deployed in live clinical eye care environments, demonstrating meaningful reductions in administrative workload and improvements in patient appointment adherence. As healthcare organizations increasingly seek AI solutions that deliver immediate ROI and integrate seamlessly with existing infrastructure, AVTRMed's focus on performance and enterprise deployment positions the company to capture value in a market undergoing fundamental transformation.
NVIDIA Inception fuels AVTRMed's ability to scale and future-proof its platform without compromising the rigorous security and compliance that healthcare demands.
For more information about AVTRMed and its AI platform, visit AVTRMed.com or connect with the company on LinkedIn.
About AVTRMed, Inc.
AVTRMed is a healthcare AI company building scalable platforms that augment clinical and operational workflows through advanced artificial intelligence. The company's mission is to enable more efficient, accessible and human-centered healthcare delivery. AVTRMed's AI Clinic Assistant platform serves eye care practices with autonomous solutions for patient engagement and administrative automation. Learn more at www.avtrmed.com.
About NVIDIA Inception
NVIDIA Inception is designed to nurture startups revolutionizing industries with technological advancements. The program provides critical go-to-market support, expertise, and technology to members across the globe, spanning diverse industries from healthcare and finance to automotive and manufacturing. For more information, visit nvidia.com/en-us/startups.
END
Media Contact:
Brian Regan, COO
Phone: (919) 229-9594
Email: [email protected]
SOURCE: AVTRMed
View the original press release on ACCESS Newswire
A.Clark--AT